J. F. Moctezuma-Ríos

Factors associated to COVID-19 vaccine acceptance in Mexican patients with rheumatic diseases: A cross-sectional and multicenter study

I. Peláez-Ballestas, Alfonso Gastelum-Strozzi, D. Galarza-Delgado, 2022, Human vaccines & immunotherapeutics.

The Use of Glucocorticoids by Rheumatologic Patients Before Attending a Specialized Department in México

R. Burgos-Vargas, J. Vázquez-Mellado, C. García-García, 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

POS1242 FACTORS ASSOCIATED WITH MORTALITY IN PATIENTS WITH RHEUMATIC DISEASES AND COVID-19 IN MEXICO

E. Zamora, F. Irazoque-Palazuelos, A. Sánchez-Rodríguez, 2021, Annals of the Rheumatic Diseases.

POS1245 MORTALITY OF COVID-19 IN PATIENTS WITH RHEUMATIC DISEASES: COMPARISON TO THE GENERAL POPULATION IN MÉXICO

E. Zamora, F. Irazoque-Palazuelos, D. Vega-Morales, 2021 .

Perception of risk and impact of the COVID-19 pandemic on patients with rheumatic diseases: a case–control study

I. Peláez-Ballestas, Alfonso Gastelum-Strozzi, C. García-García, 2022, Clinical Rheumatology.

Qualitative validation of audiovisual educational material for use on rheumatoid arthritis patients

I. Peláez-Ballestas, J. Montiel-Hernández, C. García-García, 2021, Rheumatology International.

Sociocultural and moral narratives influencing the decision to vaccinate among rheumatic disease patients: a qualitative study

I. Peláez-Ballestas, Amaranta Manrique de Lara, E. Álvarez-Hernández, 2023, Clinical rheumatology.

The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study

I. Peláez-Ballestas, Amaranta Manrique de Lara, D. Galarza-Delgado, 2023, Rheumatology International.

Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023.

L. Andrade-Ortega, M. Martínez-Martínez, F. Irazoque-Palazuelos, 2024, Reumatologia clinica.